Potential of alfacalcidol for reducing increased risk of falls and fractures (Q46153173)

20 December 2017

title

Potential of alfacalcidol for reducing increased risk of falls and fractures (English)

1 reference

20 December 2017

author name string

J D Ringe

series ordinal

1

1 reference

20 December 2017

E Schacht

series ordinal

2

1 reference

20 December 2017

publication date

22 January 2009

1 reference

20 December 2017

Rheumatology International

published in

1 reference

20 December 2017

volume

29

1 reference

20 December 2017

issue

10

1 reference

20 December 2017

page(s)

1177-1185

1 reference

20 December 2017

The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00296-008-0835-X

Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00296-008-0835-X

Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).

21 January 2018

1 reference

12 December 2020

Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.

1 reference

12 December 2020

Alfacalcidol versus plain vitamin D in inflammation induced bone loss.

1 reference

12 December 2020

Prevention of corticosteroid-induced osteoporosis by alfacalcidol

1 reference

12 December 2020

Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study

1 reference

12 December 2020

Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss

1 reference

12 December 2020

Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study

1 reference

12 December 2020

Muscle strength, functional mobility and vitamin D in older women

1 reference

12 December 2020

Use of oral corticosteroids and risk of fractures.

1 reference

12 December 2020

Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of <65 ml/min

1 reference

12 December 2020

Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis

1 reference

12 December 2020

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

1 reference

12 December 2020

The anabolic effect of human PTH (1–34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate—is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?

1 reference

12 December 2020

Muscle strength in the elderly: its relation to vitamin D metabolites.

1 reference

12 December 2020

Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates

1 reference

12 December 2020

Curative effect of combined treatment with alendronate and 1 alpha-hydroxyvitamin D3 on bone loss by ovariectomy in aged rats

1 reference

12 December 2020

Do all hip fractures result from a fall?

1 reference

12 December 2020

The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents

1 reference

12 December 2020

Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation

1 reference

12 December 2020

Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriol

1 reference

12 December 2020

In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue

1 reference

12 December 2020

Treatment with active vitamin D metabolites and concurrent treatments in the prevention of hip fractures: a retrospective study

1 reference

12 December 2020

A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min

1 reference

12 December 2020

Vitamin D receptor expression in human muscle tissue decreases with age.

1 reference

12 December 2020

Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis with calcitriol or calcium

1 reference

12 December 2020

Myopathy in Bone Loss of Ageing: Improvement by Treatment with 1α-hydroxycholecalciferol and Calcium

1 reference

12 December 2020

Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol

1 reference

12 December 2020

Which circulating level of 25-hydroxyvitamin D is appropriate?

1 reference

12 December 2020

Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.

1 reference

12 December 2020

Multifactorial pathogenesis of falls as a basis for multifactorial interventions.

1 reference

12 December 2020

Role of vitamin D in skeletal muscle function

1 reference

12 December 2020

Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis

1 reference

12 December 2020

Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women

1 reference

12 December 2020

Differential effects of D-hormone analogs and native vitamin D on the risk of falls: a comparative meta-analysis

1 reference

12 December 2020

Vitamin D: its role and uses in immunology

1 reference

12 December 2020

Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.

1 reference

12 December 2020

Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol

1 reference

12 December 2020

Vitamin D Metabolism and Function

1 reference

12 December 2020

Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis?

1 reference

12 December 2020

Vitamin D analogs as therapeutic agents: a clinical study update

1 reference

12 December 2020

Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup

1 reference

12 December 2020

Monofluorophosphate combined with hormone replacement therapy in postmenopausal osteoporosis. An open-label pilot efficacy and safety study.

1 reference

12 December 2020

Vitamin D analogs: from renal bone disease to osteoporosis

1 reference

12 December 2020

Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate

1 reference

12 December 2020

Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

1 reference

12 December 2020

Effect of Vitamin D on falls: a meta-analysis

1 reference

12 December 2020

10.1007/S00296-008-0835-X

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017